During the past decade, Sentara Cancer Institute at Sentara Norfolk General Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 13 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sentara Cancer Institute at Sentara Norfolk General Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 20 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "American College of Surgeons" with 1 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator and "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Sentara Cancer Institute at Sentara Norfolk General Hospital" are "Prostate Cancer" (5 trials), "Head and Neck Cancer" (4 trials), "Breast Cancer" (3 trials), "Bladder Cancer" (2 trials) and "Lung Cancer" (2 trials). Many other conditions were trialed in "Sentara Cancer Institute at Sentara Norfolk General Hospital" in a lesser frequency.

Most popular intervention types in "Sentara Cancer Institute at Sentara Norfolk General Hospital" are "Drug" (17 trials), "Radiation" (13 trials), "Procedure" (3 trials), "Biological" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "cisplatin" (5 trials), "paclitaxel" (3 trials), "radiation therapy" (3 trials), "cetuximab" (2 trials) and "neoadjuvant therapy" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sentara Cancer Institute at Sentara Norfolk General Hospital" are 11 trials for "All" genders, 6 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Sentara Cancer Institute at Sentara Norfolk General Hospital". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Sentara Cancer Institute at Sentara Norfolk General Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Sentara Cancer Institute at Sentara Norfolk General Hospital, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".